Updated Data on Gilteritinib in AML

Updated Data on Gilteritinib in AML

obr

1 year
24 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School comments on the importance of the updated data on gilteritinib in acute myeloid leukemia (AML).
Up Next Autoplay